TAMOXIFEN AND PREVENTION - REPLY

被引：0
|
作者：
FUGHBERMAN, A
EPSTEIN, SS
机构：
来源：
LANCET | 1993年 / 341卷 / 8846期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：695 / 695
页数：1
相关论文
共 50 条
  • [1] Tamoxifen for breast-cancer prevention - Reply
    Cuzick, J
    Forbes, J
    Howell, A
    LANCET, 2003, 361 (9352): : 178 - 178
  • [2] TAMOXIFEN AND PREVENTION
    URSIN, G
    SPICER, DV
    PIKE, MC
    LANCET, 1993, 341 (8846): : 693 - 694
  • [3] Exemestane tamoxifen? Reply
    Coombes, R. C.
    Kilburn, L. S.
    Snowdon, C. F.
    Bliss, J. M.
    LANCET, 2007, 369 (9573): : 1600 - 1601
  • [4] TAMOXIFEN THERAPY - REPLY
    ERNST, DS
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1993, 149 (06) : 793 - 794
  • [5] TAMOXIFEN FOR MASTALGIA - REPLY
    FENTIMAN, IS
    CALEFFI, M
    BRAME, K
    CHAUDARY, MA
    HAYWARD, JL
    LANCET, 1986, 1 (8482): : 681 - 681
  • [6] TAMOXIFEN AND THE GYNECOLOGIST - REPLY
    NEVEN, P
    SHEPHERD, JH
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (07): : 646 - 646
  • [7] SSRIs and tamoxifen reply
    Andersohn, Frank
    Willich, Stefan N.
    BRITISH MEDICAL JOURNAL, 2010, 340
  • [8] Tamoxifen: Prevention or provocation?
    Gurjal, A
    Andersen, JC
    Haggood, A
    Aranha, O
    Lachant, NA
    BLOOD, 2000, 96 (11) : 83B - 83B
  • [9] TAMOXIFEN IN THE PREVENTION OF OSTEOPOROSIS
    OBRECHT, JP
    HEILMANN, HP
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (38) : 1465 - 1465
  • [10] Tamoxifen in hepatocellular carcinoma - Reply
    Gallo, C
    Daniele, B
    Gaeta, GB
    Perrone, F
    Pignata, S
    LANCET, 1998, 352 (9130): : 820 - 820
12345